Home / Recalls / American Regent, Inc. / D-0507-2024

D-0507-2024 Class II Terminated

Recalled by American Regent, Inc. — New Albany, OH

Recall Details

Product Type
Drugs
Report Date
May 29, 2024
Initiation Date
May 13, 2024
Termination Date
December 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,352 vials

Product Description

Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01

Reason for Recall

Subpotent product in addition to having out-of-specification results for impurities.

Distribution Pattern

USA Nationwide

Code Information

Lot #: 23061L1C0, Exp 1/31/2025

Other recalls by American Regent, Inc.

  • D-0399-2025 Class II — niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single (April 18, 2025)
  • D-0398-2025 Class II — niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single (April 18, 2025)
  • D-0080-2025 Class II — Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), (November 11, 2024)
  • D-0082-2025 Class II — Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), (November 11, 2024)
  • D-0081-2025 Class II — Venofer (iron sucrose) Injection, USP 50 mg Elemental Iron per 2.5 mL (20 mg/mL) (November 11, 2024)
  • D-0503-2024 Class II — niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Si (May 14, 2024)